Sivik Global Healthcare LLC

In its 13F for Q4 2024 (holdings as of December 31, 2024, filed January 23, 2025), Sivik Global Healthcare LLC reported 36 stock positions worth $180.8 million. Its top holding was SS SPDR S&P Biotech ETF (XBI) at 10.0% of the portfolio, followed by Eli Lilly (LLY, 6.4%) and Boston Scientific (BSX, 5.4%). Compared with Q3 2024, it opened 12 new positions, sold out of 9, added to 6 and reduced 16. The biggest buy was a new position in Unitedhealth (UNH) and the biggest sale an exit from Intuitive Surgical (ISRG).

Most Recent 13F
Q2 2026
Location
GREENWICH, CT
CIK
0001596452
Portfolio Value
$180.8M (Q4 2024)
SEC Filing
0001596452-25-000003 ↗ filed Jan 23, 2025

Holdings Value

0$100.0M$200.0M$300.0M Q1 2024: $275.1M Q1 2024 Q2 2024: $223.9M Q2 2024 Q3 2024: $234.6M Q3 2024 Q4 2024: $180.8M $180.8M Q4 2024 Q1 2025: $182.9M Q1 2025 Q2 2025: $223.6M Q2 2025 Q3 2025: $190.5M Q3 2025 Q4 2025: $204.8M Q4 2025 Q1 2026: $131.7M Q1 2026 Q2 2026: $131.7M Q2 2026

Holdings 36 stocks · $180.8M
XBI SS SPDR S&P Biotech ETF 9.96% 200,000 $18.0M Reduce -33.3%
LLY Eli Lilly & Co. 6.40% 15,000 $11.6M Add +3.5%
BSX Boston Scientific Corp. 5.43% 110,000 $9.8M Add +4.8%
MCK McKesson Corp. 4.73% 15,000 $8.5M Reduce -25.0%
SYK Stryker Corp. 3.98% 20,000 $7.2M Reduce -25.9%
THC Tenet Healthcare Corp. 3.84% 55,000 $6.9M Reduce -15.4%
UHS Universal Health Services-B 3.72% 37,500 $6.7M Reduce -16.7%
UNH Unitedhealth Group Inc. 3.50% 12,500 $6.3M New
NVO Novo-Nordisk A/S-Spons ADR 3.33% 70,000 $6.0M Reduce -22.2%
HCA HCA Healthcare Inc. 3.32% 20,000 $6.0M No change
CAH Cardinal Health Inc. 3.27% 50,000 $5.9M Add +11.1%
DHR Danaher Corp. 3.17% 25,000 $5.7M Reduce -16.7%
ABT Abbott Laboratories 3.13% 50,000 $5.7M Reduce -16.7%
COR Cencora Inc. 3.11% 25,000 $5.6M No change
VRTX Vertex Pharmaceuticals Inc. 2.89% 13,000 $5.2M Add +30.0%
WAT Waters Corp. 2.87% 14,000 $5.2M New
HUM Humana Inc. 2.81% 20,000 $5.1M Add +100.0%
A Agilent Technologies Inc. 2.60% 35,000 $4.7M New
ABBV Abbvie Inc. 2.46% 25,000 $4.4M New
SGRY Surgery Partners Inc. 2.34% 200,000 $4.2M Reduce -13.0%
AVTR Avantor Inc. 2.33% 200,000 $4.2M Reduce -20.0%
EHC Encompass Health Corp. 2.30% 45,000 $4.2M Reduce -10.0%
BMY Bristol-Myers Squibb Co. 2.19% 70,000 $4.0M New
EW Edwards Lifesciences Corp. 2.05% 50,000 $3.7M New
CI The Cigna Group 1.83% 12,000 $3.3M New
BIO Bio-Rad Laboratories-A 1.82% 10,000 $3.3M New
SNN Smith & Nephew PLC -Spon ADR 1.70% 125,000 $3.1M Reduce -10.7%
SEM Select Medical Holdings Corp. 1.56% 150,000 $2.8M Add +7.1%
ZTS Zoetis Inc. 1.35% 15,000 $2.4M New
ZBH Zimmer Biomet Holdings Inc. 1.17% 20,000 $2.1M Reduce -50.0%
ACHC Acadia Healthcare Co. Inc. 1.10% 50,000 $2.0M Reduce -56.5%
BNTX Biontech SE-ADR 0.94% 15,000 $1.7M New
ALNY Alnylam Pharmaceuticals Inc. 0.91% 7,000 $1.6M New
RGEN Repligen Corp. 0.80% 10,000 $1.4M Reduce -60.0%
SRPT Sarepta Therapeutics Inc. 0.67% 10,000 $1.2M New
MRVI Maravai Lifesciences Hldgs-A 0.42% 140,000 $763K Reduce -67.1%

Options reported separately and not counted above: ISRG puts ($7.8M), MDGL puts ($1.2M).

Portfolio Sells Q3 2024 → Q4 2024
ISRG Intuitive Surgical Inc. Sold out 0.00% −3.66
XBI SS SPDR S&P Biotech ETF Reduce -33.3% 9.96% −2.67
BDX Becton Dickinson and Co. Sold out 0.00% −2.57
BAX Baxter International Inc. Sold out 0.00% −2.43
MDT Medtronic PLC Sold out 0.00% −2.30
RVTY Revvity Inc. Sold out 0.00% −2.18
WST West Pharmaceutical Services Sold out 0.00% −2.18
ACHC Acadia Healthcare Co. Inc. Reduce -56.5% 1.10% −2.01
TEVA Teva Pharmaceutical-SP ADR Sold out 0.00% −1.31
NVO Novo-Nordisk A/S-Spons ADR Reduce -22.2% 3.33% −1.24
STVN Stevanato Group SPA Sold out 0.00% −1.19
MRVI Maravai Lifesciences Hldgs-A Reduce -67.1% 0.42% −1.08
SGRY Surgery Partners Inc. Reduce -13.0% 2.34% −0.82
RGEN Repligen Corp. Reduce -60.0% 0.80% −0.79
THC Tenet Healthcare Corp. Reduce -15.4% 3.84% −0.77
UHS Universal Health Services-B Reduce -16.7% 3.72% −0.67
ZBH Zimmer Biomet Holdings Inc. Reduce -50.0% 1.17% −0.67
ASND Ascendis Pharma A/S Sold out 0.00% −0.64
AVTR Avantor Inc. Reduce -20.0% 2.33% −0.43
DHR Danaher Corp. Reduce -16.7% 3.17% −0.38
SYK Stryker Corp. Reduce -25.9% 3.98% −0.18
SNN Smith & Nephew PLC -Spon ADR Reduce -10.7% 1.70% −0.16
ABT Abbott Laboratories Reduce -16.7% 3.13% +0.21
EHC Encompass Health Corp. Reduce -10.0% 2.30% +0.24
MCK McKesson Corp. Reduce -25.0% 4.73% +0.51

Portfolio Buys Q3 2024 → Q4 2024
UNH Unitedhealth Group Inc. New 3.50% +3.50
WAT Waters Corp. New 2.87% +2.87
A Agilent Technologies Inc. New 2.60% +2.60
ABBV Abbvie Inc. New 2.46% +2.46
BMY Bristol-Myers Squibb Co. New 2.19% +2.19
EW Edwards Lifesciences Corp. New 2.05% +2.05
CI The Cigna Group New 1.83% +1.83
BIO Bio-Rad Laboratories-A New 1.82% +1.82
BSX Boston Scientific Corp. Add +4.8% 5.43% +1.68
HUM Humana Inc. Add +100.0% 2.81% +1.46
ZTS Zoetis Inc. New 1.35% +1.35
CAH Cardinal Health Inc. Add +11.1% 3.27% +1.15
BNTX Biontech SE-ADR New 0.94% +0.94
LLY Eli Lilly & Co. Add +3.5% 6.40% +0.93
VRTX Vertex Pharmaceuticals Inc. Add +30.0% 2.89% +0.91
ALNY Alnylam Pharmaceuticals Inc. New 0.91% +0.91
SRPT Sarepta Therapeutics Inc. New 0.67% +0.67
SEM Select Medical Holdings Corp. Add +7.1% 1.56% −0.52

Options Activity Q3 2024 → Q4 2024
ISRG Intuitive Surgical Inc. put New 15,000 $7.8M
MDGL Madrigal Pharmaceuticals Inc. put New 4,000 $1.2M
PUT - SPY 100 @ 565 EXP 10/31/2024 put Sold out 1,500 $861Kbefore exit
PUT - SPY 100 @ 553 EXP 10/31/2024 put Sold out 1,300 $746Kbefore exit

Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 34$131.7MXBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK
Q1 2026 34$131.7MXBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK
Q4 2025 41$204.8MXBI, LLY, THC, MCK, HCA
Q3 2025 35$190.5MXBI, LLY, HCA, THC, DHR
Q2 2025 38$223.6MXBI, THC, HCA, MCK, UHS
Q1 2025 29$182.9MXBI, BSX, THC, HCA, LLY
Q4 2024 36$180.8MXBI, LLY, BSX, MCK, SYK
Q3 2024 33$234.6MXBI, LLY, THC, NVO, UHS
Q2 2024 37$223.9MLLY, NVO, MCK, THC, BSX
Q1 2024 46$275.1MXBI, LLY, NVO, BSX, TMO